Congenital deficiency of 11β-hydroxysteroid dehydrogenase “apparent mineralocorticoid excess syndrome”: Diagnostic value of urinary free cortisol and cortisone

Journal of Endocrinological Investigation

Volumn 24, Issue 1, 2001, Pages 17-23

  Palermo, M ^a   Delitala, G ^a   Mantero, F ^a   Stewart, P M ^a   Shackleton, C H L ^a  

^a Cattedra di Endocrinologia   (Italy)

Author keywords

Apparent mineralocorticoid syndrome; Cortisol; Cortisone; Gas chromatography mass spectrometry; Hypertension

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; HYDROCORTISONE; KIDNEY ENZYME; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASE; ISOENZYME;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INACTIVATION; FEMALE; GAS CHROMATOGRAPHY; GENE MUTATION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERALDOSTERONISM; HYPERTENSION; IN VIVO STUDY; KIDNEY; MALE; MASS SPECTROMETRY; AGING; ENZYMOLOGY; GENETICS; LIVER; MASS FRAGMENTOGRAPHY; MUTATION; REFERENCE VALUE; SYNDROME; URINE;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADULT; AGING; CHILD; CORTISONE; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; LIVER; MALE; MUTATION; REFERENCE VALUES; SYNDROME;

EID: 0034745750     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343803     Document Type: Article

References (27)

1. Apparent mineralocorticoid excess syndrome
2. The hypertension of apparent mineralocorticoid excess “AME” syndrome
3. Mineralocorticoid activity of licorice: 11beta-hydroxysteroid dehydrogenase comes of age
4. Congenital and acquired syndrome of apparent mineralocorticoid excess
5. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
6. Cortisol to cortisone: Glucocorticoid to mineralocorticoid
7. A new form of the syndrome of apparent mineralocorticoid excess
8. Structure and function of the hepatic form of 11β-hydroxysteroid dehydrogenase in the squirrel monkey, an animal model of glucocorticoid resistance
9. 11β-hydroxysteroid dehydrogenase: Implications for clinical medicine
10. Cortisol metabolism in human obesity: Impaired cortisone-cortisol conversion in subjects with central obesity
11. Expression of 11β-hydroxysteroid dehydrogenase along the nephron of mammals and humans
12. Immunohistochemical localization of 11β-hydroxysteroid dehydrogenase type 2 enzyme in human kidney and placenta
13. Human placental 11β-hydroxysteroid dehydrogenase: Evidence for and partial purification of a distinct NAD-dependent isoform
14. Human hypertension caused by mutation in the kidney isozyme of 11β-hydroxysteroid dehydrogenase
15. Molecular basis for hypertension in the "type 2 variant" of apparent mineralocorticoid excess
16. Pathogenesis of type 2 variant of the syndrome of apparent mineralocorticoid excess
17. Apparent mineralocorticoid excess type 2
18. Mass spectrometry in the diagnosis of steroid related disorder and in hypertension research
19. Quantitation of cortisol 3-oxo-4-ene steroids in urine using gas chromatography/mass. Spectrometry with stable isotope-labeled internal standard
20. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess
21. Apparent mineralocorticoid excess: Type I and type II
22. Cure of apparent mineralocorticoid excess by kidney transplantation
23. Defect in the HSD 11 gene encoding 11β-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxo reductase deficiency
24. A mutation in HSD11β2 gene in a family with apparent mineralocorticoid excess
25. A genetic defect resulting in mild low-renin hypertension
26. Congenital 11β-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: Corticosteroid metabolite profile of four patients and their families
27. Mutans 11beta-hydroxysteroid dehydrogenase “11-HSD2” with partial activity: Improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess